Noradrenergic lesion antagonizes desipramine-induced adaptation of NMDA receptors

European Journal of Pharmacology

Volumn 389, Issue 2-3, 2000, Pages 187-192

  Harkin, Andrew ^a   Nowak, Gabriel ^a   Paul, Ian A ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Antidepressant; Desipramine; DSP 4; Glycine; NMDA receptor; Norepinephrine

Indexed keywords

2 BROMO N (2 CHLOROETHYL) N ETHYLBENZYLAMINE; 5,7 DICHLOROKYNURENIC ACID; CITALOPRAM; DESIPRAMINE; GLYCINE; NISOXETINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN HOMOGENATE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG RECEPTOR BINDING; IC 50; MALE; MOUSE; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BENZYLAMINES; CEREBRAL CORTEX; DESIPRAMINE; FLUOXETINE; GLYCINE; KYNURENIC ACID; MALE; MICE; NOREPINEPHRINE; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0034681309     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00923-1     Document Type: Article

References (30)

1. Bakke H.K., Murison R., Walther B. Effect of central noradrenaline depletion on corticosterone levels and gastric ulcerations in rats. Brain Res. 368:1986;256-261.
2. 3H]5,7-Dichlorokynurenic acid, a novel radioligand labels NMDA receptor. Eur. J. Pharmacol. 206:1991;149-154.
3. 3H]nisoxetine autoradiography. Brain Res. 582:1992;208-214.
4. Charney D.S. Monoamine dysfunction and the pathophysiology and treatment of depression. J. Clin. Psychiatry. 59(Suppl. 14):1998;11-14.
5. Chavez-Noriega L.E., Stevens C.F. Increased transmitter release at excitatory synapses produced by direct activation of adenylate cyclase in rat hippocampal slices. J. Neurosci. 14:1994;310-317.
6. Dooley D.J., Hunziker G., Hausler A. Corticosterone secretion in the rat after DSP-4 treatment. Neurosci. Lett. 46:1984;271-274.
7. Finnegan K.T., Skratt J.J., Irwin I., DeLanney L.E., Langston J.W. Protection against DSP-4-induced neurotoxicity by deprenyl is not related to its inhibition of MAO B. Eur. J. Pharmacol. 184:1990;119-126.
8. Fritschy J.M., Grzanna R. Restoration of ascending noradrenergic projections by residual locus coeruleus neurons: compensatory response to neurotoxin-induced cell death in the adult rat brain. J. Comp. Neurol. 321:1992;421-441.
9. Gereau R.W.t., Conn P.J. Presynaptic enhancement of excitatory synaptic transmission by beta-adrenergic receptor activation. J. Neurophysiol. 72:1994;1438-1442.
10. Grzanna R., Berger U., Fritschy J.M., Geffard M. Acute action of DSP-4 on central norepinephrine axons: biochemical and immunohistochemical evidence for differential effects. J. Histochem. Cytochem. 37:1989;1435-1442.
11. 2 binding sites in the rat cerebral cortex. J. Neural Transm. 59:1984;9-23.
12. Heal D.J., Butler S.A., Prow M.R., Buckett W.R. Quantification of presynaptic alpha 2-adrenoceptors in rat brain after short-term DSP-4 lesioning. Eur. J. Pharmacol. 249:1993;37-41.
13. Heninger G., Charney D. Mechanism of action of antidepressant treatments: implications for the etiology and treatment of depressive disorders. Meltzer H. Psychopharmacology: The Third Generation of Progress. 1987;535-544 Raven Press, New York.
14. Huang N.-Y., Layer R.T., Skolnick P. Is an adaptation of NMDA receptors an obligatory step in antidepressant action? Skolnick P. Antidepressants: New Pharmacological Strategies. 1997;125-143 Humana Press, Totowa, NJ.
15. Kamisaki Y., Hamahashi T., Okada C.M., Itoh T. Clonidine inhibition of potassium-evoked release of glutamate and aspartate from rat cortical synaptosomes. Brain Res. 568:1991;193-198.
16. Kitamura Y., Zhao X.-H., Takei M., Yonemitsu O. Effects of antidepressants on the glutamatergic system in mouse brain. Neurochem. Int. 3:1991;247-253.
17. Logue M.P., Growdon J.H., Coviella I.L., Wurtman R.J. Differential effects of DSP-4 administration on regional brain norepinephrine turnover in rats. Life Sci. 37:1985;403-409.
18. Mori-Okamoto J., Namii Y., Tatsuno J. Subtypes of adrenergic receptors and intracellular mechanisms involved in modulatory effects of noradrenaline on glutamate. Brain Res. 539:1991;67-75.
19. Nowak G., Li Y., Paul I.A. Adaptation of cortical but not hippocampal NMDA receptors after chronic citalopram treatment. Eur. J. Pharmacol. 295:1996;75-85.
20. Nowak G., Redmond A., McNamara M., Paul I.A. Swim stress increases the potency of glycine at the N-methyl-D-aspartate receptor complex. J. Neurochem. 64:1995;925-927.
21. 1-adrenergic up-regulation in the rat cerebral cortex. J. Neurochem. 56:1991;914-916.
22. Paul I.A. NMDA receptors and affective disorders. Skolnick P. Antidepressants: New Pharmacological Strategies. 1997;145-158 Humana Press, Totowa, NJ.
23. Paul I.A., Layer R.T., Skolnick P., Nowak G. Adaptation of the NMDA receptor in rat cortex following chronic electroconvulsive shock or imipramine. Eur. J. Pharmacol. 247:1993;305-311.
24. Paul I.A., Nowak G., Layer R.T., Popik P., Skolnick P. Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments. J. Pharmacol. Exp. Ther. 269:1994;95-102.
25. Redmond A.M., Kelly J.P., Leonard B.E. Behavioural and neurochemical effects of dizocilpine in the olfactory bulbectomized rat model of depression. Pharmacol. Biochem. Behav. 58:1997;355-359.
26. Reynolds I.J., Miller R.J. Tricyclic antidepressants block N-methyl-D-aspartate receptors: similarities to the action of zinc. Br. J. Pharmacol. 95:1988;95-102.
27. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150:1985;76-85.
28. 3H]nisoxetine: a radioligand for quantitation of norepinephrine uptake sites by autoradiography or by homogenate binding. J. Pharmacol. Exp. Ther. 260:1992;427-436.
29. Theron C.N., de Villiers A.S., Taljaard J.J. Effects of DSP-4 on monoamine and monoamine metabolite levels and on beta adrenoceptor binding kinetics in rat brain at different times after administration. Neurochem. Res. 18:1993;1321-1327.
30. Yu P.H., Davis B.A., Fang J., Boulton A.A. Neuroprotective effects of some monoamine oxidase-B inhibitors against DSP-4-induced noradrenaline depletion in the mouse hippocampus. J. Neurochem. 63:1994;1820-1828.